Neuropeptidases in cortical areas and in the cerebellum in Alzheimer's disease: Region-specific alterations lead to modified catabolic fate of somatostatin(1–14)
Carole Ichaï(University of Bern), Frédéric Checler(Centre National de la Recherche Scientifique), Nathalie Chevallier(University of California, San Diego), P. Delaère(Pitié-Salpêtrière Hospital), Pascal Dournaud(Délégation Paris 7), Jean‐Pierre Vincent(Université Paris Cité), Jacques Epelbaum(Centre National de la Recherche Scientifique), J.J. Hauw(Service de la Santé Publique)
Cited by 0
Related Papers
Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease
|Nature Genetics|2017|1.1k
Clinical practice guideline on diagnosis and treatment of hyponatraemia
|Intensive Care Medicine|2014|1k
Clinical practice guideline on diagnosis and treatment of hyponatraemia
|European Journal of Endocrinology|2014|823
Early enteral nutrition in critically ill patients: ESICM clinical practice guidelines
|Intensive Care Medicine|2017|816
Clinical practice guideline on diagnosis and treatment of hyponatraemia
|Nephrology Dialysis Transplantation|2014|555